**Specifications table**TableSubject area*Biology*More specific subject area*Immunology*Type of data*Tables and Figures*How data was acquired*Multiplex Elisa, qRT-PCR*Data format*Analyzed*Experimental factors*Broncho-alveolar lavage fluid and lung homogenate obtained after in vivo exposure to cigarette smoke and/or vitamin D deficiency post-infection with NTHi*Experimental features*mRNA and protein expression of inflammatory cytokines and key markers of bacterial clearance pathways*Data source location*Leuven, Belgium*Data accessibility*Within this article*Related research article*Jef Serré, Carolien Mathyssen, Tom Tanjeko Ajime, Hannelie Korf, Karen Maes, Nele Heulens, Conny Gysemans, Chantal Mathieu, Bart Vanaudenaerde, Wim Janssens, Ghislaine Gayan-Ramirez; Airway infection with Nontypeable Haemophilus influenza is more rapidly eradicated in vitamin D deficient mice; the journal of steroid biochemistry and molecular biology, available online November 2018, In Press,*[@bib1].

**Value of the data**•Model to assess bacterial clearance during infection to compare with other bacteria.•This dataset provides more insight in the inflammatory cytokine response during an infection with NTHi.•This dataset shows the activation of multiple antimicrobial pathways.•A protocol for the detection of chromosomal bacterial DNA of NTHi in lung homogenate.

1. Data {#s0005}
=======

The data in this article acts as supplementary analysis that were performed in [@bib1]. [Table 1](#t0005){ref-type="table"} summarizes the levels of pro-inflammatory cytokines measured in BALF before and after infection with NTHi in both groups. [Table 2](#t0010){ref-type="table"} shows the primer sequences of the studied genes while [Table 3](#t0015){ref-type="table"} reports mRNA expression levels of these genes per group during and after infection. Myeloperoxidase and nitric oxide production in BALF for both groups are given in [Table 4](#t0020){ref-type="table"}. [Fig. 1](#f0005){ref-type="fig"} depicts protein levels of complement C5a and immunoglobulin A in BALF during infection in each group. Chromosomal DNA concentration of NTHi in lung homogenate measured over time is shown on [Fig. 2](#f0010){ref-type="fig"} for both groups.Table 1Faster resolution of pro-inflammatory mediators in vitamin D deficient mice compared to vitamin D sufficient mice. KC, TNF-α, IL-6, IL-1β and MCP-1 was determined in BALF in sufficient and vitamin D deficient mice (*n* = 6 mice/group/time point). Data are presented in pg/ml.Table 1Target**DIETBaseline**Post-infection**4 h8 h24 h72 h**KC (pg/ml)**Sufficient**6.56 ± 1.367199 ± 14662243 ± 100437.66 ± 28.0724.21 ± 8.33**Deficient**6.33 ± 2.427443 ± 991.51769 ± 129532.69 ± 17.6826.45 ± 12.22TNF-α (pg/ml)**Sufficient**5.57 ± 1.226127 ± 274.95455 ± 612.8517.3 ± 130.9112.2 ± 34.89**Deficient**3.25 ± 1.376083 ± 318.74303 ± 1084478.1 ± 248.134.89 ± 14.89 ([\*](#tbl1fnStar){ref-type="table-fn"})IL-6 (pg/ml)**Sufficient**2.82 ± 2.4826214 ± 785727908 ± 51294257 ± 2240270.2 ± 139.1**Deficient**1.84 ± 0.9928356 ± 570820300 ± 63972740 ± 186049.88 ± 20.16 ([\*\*](#tbl1fnStarStar){ref-type="table-fn"})IL-1β (pg/ml)**Sufficient**0.22 ± 0.3013.15 ± 7.4048.17 ± 15.5617.27 ± 12.182.90 ± 2.41**Deficient**0.07 ± 0.1012.41 ± 5.4934.97 ± 12.5017.20 ± 8.751.34 ± 1.09MCP-1 (pg/ml)**Sufficient**/103.3 ± 58.3332.74 ± 20.57178.1 ± 111.725.88 ± 11.56**Deficient**/84.52 ± 35.1124.66 ± 6.4383.97 ± 32.7027.87 ± 11.57[^1][^2][^3]Table 2Primer sequences of the house keeping gene (RPL27), mucin glycoproteins (MUC5AC, MUC5B), a pathogen recognition receptor (TLR2, TLR4), the antimicrobial peptides (SLPI, Lysozyme, REG3γ, CRAMP, BD 1--3), the surfactant proteins (SP-A, SP-D), the tissue inhibitor of matrix metalloproteinase (TIMP1) and the matrix metalloproteinases (MMP9 and MMP12). Primer efficiency is in the range of 90--105%.Table 2TargetForward primerReverse primerAccession IDRPL275'-GTCGAGATGGGCAAGTTCAT-3'5'-TTCTTCACGATGACGGCTTT-3'[NM_011289.3](ncbi-n:NM_011289.3){#ir0005}MUC5AC5'-CTGTAACACCCAGTGTCCTAAG-3'5'-AGGCTGGTAGAAGTAGGTAGAA-3'[NM_010844.1](ncbi-n:NM_010844.1){#ir0010}MUC5B5'-CCGTCCTCTTTCCCAACATATC-3'5'-TCACTCTGCTTGCTGTTTCTAC-3'[NM_028801.2](ncbi-n:NM_028801.2){#ir0015}TLR25'-CACTATCCGGAGGTTGCATATC-3'5'-GGAAGACCTTGCTGTTCTCTAC-3'[NM_011905.3](ncbi-n:NM_011905.3){#ir0020}TLR45'-GGGTATTTGACACCCTCCATAG-3'5'-CAAGAGTGCTGAGGGAATACAG-3'[NM_021297.3](ncbi-n:NM_021297.3){#ir0025}BD-15'-AGCCAGGTGTTGGCATTCTC-3'5'-GCTTATCTGGTTTACAGGTTCCC-3'[NM_007843.3](ncbi-n:NM_007843.3){#ir0030}BD-25'-GCCATGAGGACTCTCTGCTC-3'5'-GGACAAATGGCTCTGACACA-3'[NM_010030.1](ncbi-n:NM_010030.1){#ir0035}BD-35'-GTCATGAGGATCCATTACCTTCT-3'5'-CGGGATCTTGGTCTTCTCTATTT-3'[NM_013756.2](ncbi-n:NM_013756.2){#ir0040}SLPI5'-GCTGTGAGGGTATATGTGGGAA-3'5'-CGCCAATGTCAGGGATCAG-3'[NM_011414.3](ncbi-n:NM_011414.3){#ir0045}Lysozyme5'-ATGGAATGGCTGGCTACTATG-3'5'-GGTCTCCACGGTTGTAGTTT-3'[NM_017372.3](ncbi-n:NM_017372.3){#ir0050}REG3γ5'-TGCCTATGGCTCCTATTGCT-3'5'-CACTCCCATCCACCTCTGTT-3'[NM_011260.1](ncbi-n:NM_011260.1){#ir0055}CRAMP5'-ACCAATCTCTACCGTCTCCT-3'5'-CTCTGCCTTGCCACATACA-3'[NM_009921.2](ncbi-n:NM_009921.2){#ir0060}SP-A5'-GGCATACCAACTGCTCTCTT-3'5'-GCTTACCGGAAGACAGACTAAC-3'[NM_023134.4](ncbi-n:NM_023134.4){#ir0065}SP-D5'-AAGGCTGCTTTCCTGAGTATG-3'5'- CCTGGAGCCCAATTAGAATAGAC-3'[NM_009160.2](ncbi-n:NM_009160.2){#ir0070}TIMP15'-GTGGGAAATGCCGCAGAT-3'5'-GGGCATATCCACAGAGGCTTT-3'[NM_011593.2](ncbi-n:NM_011593.2){#ir0075}[NM_001294280.2](ncbi-n:NM_001294280.2){#ir0080}[NM_001044384.1](ncbi-n:NM_001044384.1){#ir0085}MMP95'-TTCCCCAAAGACCTGAAAAC-3'5'-TGCTTCTCTCCCATCATCTG-3'[NM_013599.4](ncbi-n:NM_013599.4){#ir0090}MMP125'-TTTTGATGGCAAAGGTGGTA-3'5'-GCCTCATCAAAATGCCGCAGAT-3'[NM_008605.3](ncbi-n:NM_008605.3){#ir0095}[NM_001320076.1](ncbi-n:NM_001320076.1){#ir0100}[NM_001320077.1](ncbi-n:NM_001320077.1){#ir0105}Table 3mRNA expression of antimicrobial pathway markers are similarly enhanced in both group with infection except for B-defensins that could not be detected. Mucin glycoproteins (MUC5AC, MUC5B), a pathogen recognition receptor (TLR2, TLR4), the antimicrobial peptides (SLPI, Lysozyme, REG3γ, CRAMP, BD 1--3), surfactant proteins (SP-A, SP-D) were determined in lung homogenate (n = 6 mice/group/time point). Data are expressed as fold change relative to RPL27 as mean ± SD.Table 3Target**DIETBaseline**Post-infection**4 h8 h24 h72 h**MUC5AC**Sufficient**1.39 ± 1.452.13 ± 0.831.35 ± 0.482.42 ± 2.105.28 ± 1.59**Deficient**0.85 ± 0.661.87 ± 1.021.60 ± 0.792.15 ± 1.138.44 ± 4.85 ([\*\*](#tbl3fnStarStar){ref-type="table-fn"})MUC5B**Sufficient**1.37 ± 1.452.07 ± 0.670.84 ± 0.191.67 ± 1.402.00 ± 0.72**Deficient**1.16 ± 0.631.85 ± 0.960.87 ± 0.461.92 ± 1.093.36 ± 2.16TLR2**Sufficient**1.16 ± 0.707.98 ± 3.1610.79 ± 3.515.40 ± 2.005.06 ± 1.24**Deficient**1.39 ± 0.3710.29 ± 6.5110.72 ± 4.276.09 ± 3.423.79 ± 1.86TLR4**Sufficient**2.22 ± 1.325.21 ± 2.475.87 ± 2.814.55 ± 2.184.33 ± 1.21**Deficient**3.47 ± 0.336.35 ± 4.877.11 ± 4.086.07 ± 3.545.01 ± 2.07BD-1No detection in lung homogenate with 3 different primersBD-2No detection in lung homogenate with 3 different primersBD-3No detection in lung homogenate with 3 different primersREG3g**Sufficient**1.14 ± 0.632.64 ± 1.691.43 ± 0.995.13 ± 4.245.32 ± 1.86**Deficient**0.83 ± 0.371.81 ± 1.152.02 ± 1.054.87 ± 3.745.49 ± 2.51SLPI**Sufficient**1.18 ± 0.883.75 ± 2.526.78 ± 4.793.70 ± 3.051.23 ± 0.83**Deficient**1.00 ± 0.594.14 ± 2.376.25 ± 4.982.73 ± 2.171.26 ± 0.89Lysozyme**Sufficient**1.19 ± 0.761.37 ± 0.650.98 ± 0.461.80 ± 1.192.71 ± 0.98**Deficient**1.92 ± 0.701.40 ± 0.561.63 ± 0.741.99 ± 1.032.81 ± 1.36SP-D**Sufficient**1.13 ± 0.671.51 ± 0.462.25 ± 0.841.88 ± 0.791.32 ± 0.45**Deficient**2.05 ± 1.061.94 ± 1.082.26 ± 0.651.91 ± 0.831.45 ± 0.38SP-A**Sufficient**1.06 ± 0.500.72 ± 0.530.39 ± 0.260.47 ± 0.340.59 ± 0.53**Deficient**1.32 ± 0.570.75 ± 0.510.39 ± 0.260.46 ± 0.210.67 ± 0.45[^4]Table 4Myeloperoxidase and Nitric oxide protein levels were elevated during NTHi infection. MPO and NO were measured in BALF at baseline and at 4, 8, 24 and 72 h post-infection (*n* = 6 mice/group/time point). Data are expressed in pg/ml MPO and µM NO~2~^-^ as mean ± SD.Table 4Target**DIETBaseline**Post-infection**4 h8 h24 h72 h**MPO (pg/ml)**Sufficient**1.45 ± 0.22163.4 ± 176.2384.3 ± 41.96303.1 ± 101.2148.2 ± 12.49**Deficient**1.32 ± 0.17103.8 ± 53.89320.2 ± 95.74295.0 ± 83.91137.6 ± 30.50NO~2~^-^ (µM)**Sufficient**0.91 ± 0.541.26 ± 0.501.07 ± 0.601.61 ± 0.751.77 ± 0.44**Deficient**0.99 ± 0.131.65 ± 0.241.34 ± 0.501.30 ± 0.331.05 ± 0.48 ([\*](#tbl4fnStar){ref-type="table-fn"})[^5]Fig. 1Complement C5a and Immunoglobulin A (IgA) protein levels are enhanced to the same extent in both group during the infection period. Complement C5a and IgA protein levels were measured in BALF during infection (*n* = 6 mice/group/time point). Data are expressed in pg/ml C5a and ng/ml IgA as mean ± SD.Fig. 1Fig. 2DNA concentration of NTHi in lung homogenate was progressively and similarly reduced in both groups during the infection period. Invasiveness of NTHi was determined on lung homogenate by measuring bacterial DNA with primers for protein D (*n* = 6 mice/group/time point). Data are expressed in pg as mean ± SD.Fig. 2

2. Experimental design, materials and methods {#s0010}
=============================================

C57BL/6JolaH mice (3 weeks old) were made vitamin D deficient or sufficient through the use of a vitamin D deficient or a standard control diet respectively [@bib1]. Series 2 of [@bib1] is elaborated in more detail below. Briefly, mice were infected with NTHi at 9 weeks of age and sacrificed at baseline and 4, 8, 24 and 72 h post-infection (*n* = 6 mice/group/time point).

2.1. Pro-inflammatory mediators in the bronchoalveolar lavage {#s0015}
-------------------------------------------------------------

Pro-inflammatory cytokines KC, Tumor Necrosis Factor (TNF)-α, Monocyte Chemotactic Protein (MCP)-1, Interleukin (IL)-6 and IL-1β were measured in the BAL fluid as described in [@bib1].

2.2. mRNA expression levels of inflammatory mediators, antimicrobial markers and matrix metalloproteinases (MMP׳s) {#s0020}
------------------------------------------------------------------------------------------------------------------

Total RNA was extracted, converted to cDNA and analyzed via qRT-PCR as described in [@bib1]. Primer sequences ([Table 2](#t0010){ref-type="table"}) and mRNA expression levels ([Table 3](#t0015){ref-type="table"}) of mucin glycoproteins (MUC), pattern recognition receptors (PRR), antimicrobial peptides (AMP) and surfactant proteins (SP): MUC5AC, MUC5B, toll-like receptor (TLR) 2, TLR4, lysozyme, secreted leukocyte protease inhibitor (SLPI), β-defensin 1, 2, 3 and cathelicidin related antimicrobial peptide (CRAMP), regenerating islet-derived protein 3-gamma (REG3γ), SP-A and D used in [@bib1] are given below.

3. Myeloperoxidase and nitric oxide production in BALF {#s0025}
======================================================

Myeloperoxidase (MPO) levels were measured in BALF as described in [@bib1]. Primary metabolite of nitric oxide, nitrite (NO~2~^-^), was measured via Gries reagent kit (Thermo Fischer scientific) according to manufacturer׳s instructions.

3.1. Complement C5a and Immunoglobulin A measurement in BALF {#s0030}
------------------------------------------------------------

Complement C5a was measured in 1:100 diluted BALF, using a coated Complement C5a Mouse ELISA kit (ab193718, Abcam, Cambridge) with a range of 1.64--400 pg/ml. Immunoglobulin A (IgA) levels in BALF were measured using an IgA mouse Uncoated ELISA kit (ThermoFisher Scientific, Massachusetts) with a range of 0.39--25 ng/ml. ELISA׳s were performed according to manufacturer׳s instructions.

3.2. NTHi genomic DNA quantification {#s0035}
------------------------------------

Genomic DNA (gDNA) was extracted out of 20--25 mg lung tissue using PureLink Genomic DNA Kit (Invitrogen). Briefly, lung tissue was homogenized in 200 µl genomic digestion buffer with Proteinase K (2 mg/ml) and incubated at 56 °C overnight. Particulate material was removed by centrifugation at 12,000 *g* for 3 min. RNA was broken down by adding RNase A and incubating it at room temperature for 2 min. Column steps were executed according to manufactures instructions and gDNA was eluted in 50 µl elution buffer (10 mM Tris--HCl, pH 8.0). qPCR was performed using 160 ng gDNA, 300 nM/primer, 1 mM MgCl, 1 x KAPA SYBR® FAST master mix and 1x High rox (included in KAPA SYBR® FAST qPCR kit master mix (2×) universal, KAPAbiosystems, Boston) for one reaction. Primer set was designed for the protein D sequence on gDNA of NTHi: FOR- 5'GGCCCAGGTTGGTATAGTTAG'3, REV- 5'TCGGGCAGTGCATCTTTAC'3. Concentration gDNA of NTHi was quantified by using a 1:10 standard dilution curve with range of 65,200--0.652 pg of pure gDNA from freshly grown NTHi.

Transparency document. Supplementary material {#s0045}
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[^1]: Data are expressed as mean ± SD.

[^2]: *p*\< 0.05.

[^3]: *p*\< 0.01 (Mann-Whitney test, sufficient vs deficient).

[^4]: *p*\< 0.01 (Mann-Whitney test, sufficient vs deficient).

[^5]: *p*\< 0.05 (Mann-Whitney test, sufficient vs deficient).
